![]() |
![]() |
![]() |
|
This site is for healthcare professionals. If you are not a health care provider please contact your physician.
Methylnaltrexone is an investigational drug being investigated as a possible treatment for the peripheral side effects of opioid analgesics, without interfering with pain relief. Methylnaltrexone is being developed in three dosage forms: subcutaneous and oral forms as treatment platforms for opioid-induced constipation, and an intravenous form for post-operative ileus.